In utero lipid nanoparticle delivery achieves robust editing in hematopoietic stem cells.
Worthington, A. K.; Borges, B.; Lum, T.; Echeverri, E. S.; Zada, F. M.; Cordero, M.; Kim, H.; Zenhausern, R.; Celik, O.; Shaw, C.; Gutierrez-Martinez, P.; Omarova, M.; Blanchard, C.; Burns, S.; Cromer, K.; Dahlman, J.; MacKenzie, T.
Show abstract
In vivo genome editing for hematologic malignancies is limited by inefficient delivery of genome editors to hematopoietic stem cells (HSC) in the bone marrow. To overcome this limitation, we capitalized on the inherent liver tropism of lipid nanoparticles (LNPs) and the liver niche of fetal HSCs. We demonstrate that in utero delivery of LNPs without active targeting ligands to the fetal liver results in potentially therapeutic levels of HSC editing.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Post-Transplant Administration of G-CSF Impedes Engraftment of Gene Edited Human Hematopoietic Stem Cells by Exacerbating the p53-Mediated DNA Damage Response 96%
- Hematopoietic stem cells fail to regenerate following inflammatory challenge. 95%
- Resolving fate and transcriptome of hematopoietic stem cell clones 94%
Similar papers in this journal
- Cas9-AAV6 Gene Correction of Beta-Globin in Autologous HSCs Improves Sickle Cell Disease Erythropoiesis in Mice 95%
- Endowing Universal CAR T-cell with Immune-Evasive Properties using TALEN-Gene Editing. 94%
- Functional Screening in human HSPCs identifies optimized protein-based enhancers of Homology Directed Repair 94%
Similar papers in this journal
Similar papers in this journal
- Loss of Nupr1 promotes engraftment by tuning the quiescence threshold of hematopoietic stem cell repository via regulating p53-checkpoint pathway 94%
- HCMV control in allogeneic stem cell transplant recipients - an analysis of humoral and cellular players beyond antigen-specific T cells in the letermovir era 92%
- Genome-wide CRISPR Screens Identify Ferroptosis as a Novel Therapeutic Vulnerability in Acute Lymphoblastic Leukemia 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.